Patent advice regarding an IPO for Life Science company
BioArctic is a Swedish research-based biopharmaceutical company that develops antibody-based disease modifying treatments for neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. The company also develops an innovative treatment concept for complete spinal cord injuries.
Our patent consultant Tomas Lundquist, who has worked with BioArctic since 2014, is continuously working on building and managing BioArctic’s strategically important patent portfolio.
Prior to BioArctic’s Initial Public Offering, Tomas assisted BioArctic with analyzes of the company’s patent situation. The material highlighted all relevant aspects from a patent perspective and was used as input for various Due Diligence analyzes. During the Due Diligence procedure, Tomas assisted BioArctic by answering patent-related questions posed by parties who conducted the Due Diligence work. Tomas also assisted with patent-related information for the investment documentation used by BioArctic in presentations for potential investors.
In an IPO, the stock auditor also places high demands on the company at hand, where some parts concern patent-related issues, such as ownership and risks associated with the patent portfolio. Tomas also assisted BioActic with these matters.
BioArtics was listed on Nasdaq Stockholm Mid Cap on October 12, 2017. The company’s market value was SEK 2.11 billion (over 200 million Euro) based on the subscription price. In connection to the IPO, Tomas was specially invited as a key consultant and joined BioArctic to celebrate their success on site at Nasdaq.
For BioArctic, patent-related issues are of major strategic significance for the company’s long-term sustainability. Therefore, we invest a lot of resources and we focus strongly on managing these important tasks in the best possible way, says Gunilla Osswald, CEO of BioArctic AB.
"For BioArctic, patent-related issues are of major strategic significance for the company's long-term sustainability. Therefore, we invest a lot of resources and we focus strongly on managing these important tasks in the best possible way."